Protagonist Therapeutics Inc (PTGX)
Debt-to-assets ratio
Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long-term debt | US$ in thousands | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Total assets | US$ in thousands | 744,725 | 603,857 | 614,629 | 629,276 | 357,951 | 330,016 | 320,466 | 239,858 | 247,928 | 282,174 | 310,512 | 348,296 | 347,695 | 373,175 | 404,232 | 298,072 | 324,468 | 217,320 | 224,980 | 134,901 |
Debt-to-assets ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
December 31, 2024 calculation
Debt-to-assets ratio = Long-term debt ÷ Total assets
= $—K ÷ $744,725K
= 0.00
The debt-to-assets ratio for Protagonist Therapeutics Inc has consistently been recorded as 0.00 for the periods spanning from March 31, 2020 to December 31, 2024. This indicates that the company has had no debt in relation to its assets during this time frame. A debt-to-assets ratio of 0.00 signifies that the company's assets have been fully financed by equity rather than debt, highlighting a favorable financial position with low financial risk related to debt obligations. It suggests that the company has not relied on borrowing to fund its operations and investments, which can be viewed positively by investors and creditors.
Peer comparison
Dec 31, 2024